Agilent and Chungnam National University in Daejeon, South Korea, have announced new initiatives to further research in glycomics — the study of complex sugars — in order to develop biomarkers and new therapeutic antibodies to combat diseases such as cancer.
Agilent and the university’s Graduate School of Analytical Science and Technology will establish the Asia Glycomics Education Center to support collaborative university/industry education and cross-training. The research will develop and enhance the biosimilars industry, helping scientists develop new treatments to cure or prevent diseases.
Collaborative research between Agilent and leading academic researchers worldwide serves as the company’s means of giving back to communities in which it does business. At the Asia Glycomics Education Center, Agilent will install a state-of-the-art Agilent 6540 Quadrupole Time-of-Flight with Chip/2D nanoHPLC system. The new system will be used to develop novel applications or analytical methods in the field of glycomics and glycoproteomics.
For more information go to: